Accelerated Approval of Cancer Drugs-Righting the Ship of the US Food and Drug Administration

JAMA Intern Med. 2019 Jul 1;179(7):922-923. doi: 10.1001/jamainternmed.2019.0584.
No abstract available

Publication types

  • Comment

MeSH terms

  • Antineoplastic Agents*
  • Drug Approval*
  • United States
  • United States Food and Drug Administration

Substances

  • Antineoplastic Agents